lifastuzumab vedotin

Ligand id: 8405

Name: lifastuzumab vedotin

Classification
Compound class Antibody
International Nonproprietary Names
INN number INN
9835 lifastuzumab vedotin
Synonyms
DNIB0600A | RG-7599 | RG7599
Database Links
Specialist databases
IMGT/mAb-DB 478
Other databases
GtoPdb PubChem SID 252166615
Search PubMed clinical trials lifastuzumab vedotin
Search PubMed titles lifastuzumab vedotin
Search PubMed titles/abstracts lifastuzumab vedotin
Wikipedia Lifastuzumab vedotin
Comments
Lifastuzumab vedotin is an antibody drug conjugate containing an anti-SLC34A2 (sodium phosphate 2 transporter) monoclonal antibody linked to the toxin monomethyl auristatin E (MMAE, aka vedotin; PubChem CID 11542188).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence match identifies US8535675 as the covering patent [1], and also identifies the target antigen denoted as TAT211 in this patent as the sodium phosphate transporter.